Evidence map›Paper›PMID 29884955›Full record

ReviewCurrent hypertension reports2018

Focused Update on Pharmacologic Management of Hypertensive Emergencies.

Kristin Watson, Rachael Broscious, Sandeep Devabhakthuni, Zachary R Noel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hypertension reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Neurocritical Care of the Pregnant Patient.Current treatment options in neurology · 2021
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kristin WatsonUniversity of Maryland School of Pharmacy, 20 N Pine Street, Baltimore, MD, 21201, USA. Kristin.watson@rx.umaryland.edu.
Rachael BrosciousUniversity of Maryland School of Pharmacy, 20 N Pine Street, Baltimore, MD, 21201, USA.
Sandeep DevabhakthuniUniversity of Maryland School of Pharmacy, 20 N Pine Street, Baltimore, MD, 21201, USA.
Zachary R NoelUniversity of Maryland School of Pharmacy, 20 N Pine Street, Baltimore, MD, 21201, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewHypertensive emergency is defined as a systolic blood pressure > 180 mmHg or a diastolic blood pressure > 120 mmHg with evidence of new or progressive end-organ damage. The purpose of this paper is to review advances in the treatment of hypertensive emergencies within the last 5 years. RECENT

findingsNew literature and recommendations for managing hypertensive emergencies in the setting of pregnancy, stroke, and heart failure have been published. Oral nifedipine is now considered an alternative first-line therapy, along with intravenous hydralazine and labetalol for women presenting with pre-eclampsia. Clevidipine is now endorsed by guidelines as a first-line treatment option for blood pressure reduction in acute ischemic stroke and may be considered for use in intracranial hemorrhage. Treatment of hypertensive heart failure remains challenging; clevidipine and enalaprilat can be considered for use in this population although data supporting their use remains limited.

Indexed as

EmergenciesAdministration, OralAntihypertensive AgentsBlood PressureBrain IschemiaEnalaprilatFemaleGuideline AdherenceHeart FailureHumansHydralazineHypertensionInfusions, IntravenousIntracranial HemorrhagesLabetalolNifedipineAntihypertensive AgentsclevidipineEnalaprilatHydralazineLabetalolNifedipinePyridinesHypertensive crisis, intravenous antihypertensive medicationsHypertensive emergency

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.